Streetbeat News

Partnerships

ABOS

HALO

Acumen Pharmaceuticals, Inc. and Halozyme have entered a global collaboration and license agreement to develop a subcutaneous formulation of ACU193 with ENHANZE technology.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:31 pm

MSFT

OpenAI, backed by Microsoft Corp. (NASDAQ:MSFT), is reportedly developing a feature that allows users to create and share their own GPT models. The feature, known as 'Magic Maker', is expected to be powered by GPT-4 Magic Create, enabling users to design a unique GPT that meets their specific needs. Users can save their customized GPTs for individual use or distribute them to others via a link. This development could potentially create an ecosystem of GPT developers and consumers.

Portfolio Pulse from Rounak Jain

November 06, 2023 | 12:23 pm

DNA

Ginkgo BioWorks and XWELL are expanding their collaboration with the U.S. Centers for Disease Control and Prevention's traveler-based genomic surveillance program. They will now test for more than 30 additional priority pathogens, besides SARS-COV-2.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:15 pm

ADN

Advent Technologies has entered into a multi-million dollar, two-year joint benchmarking project with Airbus. The specifics of the project have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:13 pm

BNTX

Biotheus has signed an exclusive license and collaboration agreement with BioNTech for the global development, manufacturing, and commercialization of PM8002, excluding Greater China. PM8002 is currently in Phase 2 studies in China for the treatment of advanced solid tumors.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:12 pm

LMT

TGI

Triumph Group has secured a contract from Sikorsky, a Lockheed Martin company, to provide the main rotor blade fold actuation and dampening systems for lots 7 and 8 of the CH-53K King Stallion Rotorcraft. The work will be performed at Triumph's facility in Seattle, Washington. The terms of the contract were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 12:07 pm

NRXP

NRx Pharmaceuticals and Nephron Pharmaceuticals have signed an agreement to manufacture a version of Ketamine for treating suicidal depression. The partners aim to submit a New Drug Application by March 1, 2024, and target a finished drug with two-year shelf stability for November 2024, pending FDA approval.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 11:55 am

IBM

NWG

NatWest and IBM have partnered on a generative AI initiative aimed at improving customer experience. The collaboration will leverage IBM's expertise in AI to develop solutions that enhance customer interactions and services.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 11:51 am

MSFT

TRMB

Trimble (TRMB) has introduced an AI-powered capability to its automatic invoicing functionality, leveraging Microsoft Azure (MSFT). This new feature is expected to enhance the efficiency of Trimble's invoicing system.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 11:33 am

AULT

Ault Alliance, Inc. (NYSE:AULT) announced that its subsidiary, MTIX Ltd., has entered into a license agreement for its patented Multiplexed Laser Surface Enhancement (MLSE) technology. MTIX is a wholly owned subsidiary of Avalanche International Corp., which is majority owned by Ault Alliance.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 11:31 am